FDA Review Finds No Increased Risk of Prostate Cancer with Parkinsons Disease Medicines Containing Entacapone (Comtan, Stalevo)
Audience: Consumer, Health Professional, Pharmacy
August 13, 2019 -- A U.S. Food and Drug Administration (FDA) review of ad
FDA Approves Pretomanid
FDA Approves Pretomanid for Highly Drug-Resistant Forms of Tuberculosis
NEW YORK August 14, 2019 - Pretomanid, a novel compound developed by the non-profit organization TB Alliance, was approved by the U.S. Food & Drug Administ
FDA Approves Rozlytrek
FDA Approves Rozlytrek (entrectinib) for People With ROS1-Positive, Metastatic Non-Small Cell Lung Cancer and NTRK Gene Fusion-Positive Solid Tumors
South San Francisco, CA -- August 15, 2019 -- Genentech, a member of the Roche
FDA Approves Boxed Warning About Increased Risk of Blood Clots and Death with Higher Dose of Tofacitinib (Xeljanz, Xeljanz XR)
Audience: Consumer, Health Professional, Pharmacy
July 26, 2019 -- The U.S. Food and Drug Administration has approved new wa
HbA1c, BMI Linked to Stillbirth Risk in Women With Diabetes
FRIDAY, Aug. 9, 2019 -- Higher maternal hemoglobin A1c (HbA1c) levels are associated with increased risk for stillbirth among women with type 1 diabetes, while higher BMI increases risk for wome
Jubilant Cadista Pharmaceuticals Inc. Issues Voluntary Nationwide Recall of Drospirenone and Ethinyl Estradiol Tablets, USP, Due to Out-of-Specification Dissolution Test Results
Audience: Consumer, Health Professional, Pharmacy
July 23, 2019 -- Salisb